JNK1/2 activation by an extract from the roots of morus alba L. Reduces the viability of multidrug-resistant MCF-7/Dox cells by inhibiting YB-1-dependent Mdr1 expression

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Choi, Youn Kyung ^a   Cho, Sung Gook ^a   Choi, Hyeong Sim ^a   Woo, Sang Mi ^a   Yun, Yee Jin ^a   Shin, Yong Cheol ^a   Ko, Seong Gyu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; DOXORUBICIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 9; MULBERRY EXTRACT; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN C FOS; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE 1; Y BOX BINDING PROTEIN 1;

ARTICLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PLANT ROOT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84881523091     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/741985     Document Type: Article

References (40)

1. Fairchild C. R., Moscow J. A., O'Brien E. E., Cowan K. H., Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase- π Molecular Pharmacology 1990 37 6 801 809 2-s2.0-0025313475 (Pubitemid 20219888)
2. Jaroszewski J. W., Kaplan O., Cohen J. S., Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies. Cancer Research 1990 50 21 6936 6943 2-s2.0-0025175531 (Pubitemid 20361094)
3. Goldstein L. J., Galski H., Fojo A., Willingham M., Lai S.-L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G. M., Lieber M., Cossman J., Gottesman M. M., Pastan I., Expression of a multidrug resistance gene in human cancers. Journal of the National Cancer Institute 1989 81 2 116 124 2-s2.0-0024548599 (Pubitemid 19031328)
4. Leonard G. D., Fojo T., Bates S. E., The role of ABC transporters in clinical practice. Oncologist 2003 8 5 411 424 2-s2.0-0141888537 10.1634/theoncologist.8-5-411 (Pubitemid 37238869)
5. Shaffer B. C., Gillet J.-P., Patel C., Baer M. R., Bates S. E., Gottesman M. M., Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resistance Updates 2012 15 62 69 2-s2.0-84857851499 10.1016/j.drup.2012.02.001
6. de Souza R., Zahedi P., Badame R. M., Allen C., Piquette-Miller M., Chemotherapy dosing schedule influences drug resistance development in ovarian cancer. Molecular Cancer Therapeutics 2011 10 7 1289 1299 2-s2.0-79960130324 10.1158/1535-7163.MCT-11-0058
7. Hoffmann A.-C., Wild P., Leicht C., Bertz S., Danenberg K. D., Danenberg P. V., Stöhr R., Stöckle M., Lehmann J., Schuler M., Hartmann A., MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotheraphy. Neoplasia 2010 12 8 628 636 2-s2.0-77956044313 10.1593/neo.10402
8. Bourhis J., Benard J., Hartmann O., Boccon-Gibod L., Lemerle J., Riou G., Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. Journal of the National Cancer Institute 1989 81 18 1401 1405 2-s2.0-0024426105 (Pubitemid 19224197)
9. Bargou R. C., Jürchott K., Wagener C., Bergmann S., Metzner S., Bommert K., Mapara M. Y., Winzer K.-J., Dietel M., Dörken B., Royer H.-D., Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nature Medicine 1997 3 4 447 450 2-s2.0-16944363733 10.1038/nm0497-447 (Pubitemid 27145688)
10. Basaki Y., Hosoi F., Oda Y., Fotovati A., Maruyama Y., Oie S., Ono M., Izumi H., Kohno K., Sakai K., Shimoyama T., Nishio K., Kuwano M., Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene 2007 26 19 2736 2746 2-s2.0-34247506814 10.1038/sj.onc.1210084 (Pubitemid 46663838)
11. Kuwano M., Oda Y., Izumi H., Yang S.-J., Uchiumi T., Iwamoto Y., Toi M., Fujii T., Yamana H., Kinoshita H., Kamura T., Tsuneyoshi M., Yasumoto K., Kohno K., The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Molecular Cancer Therapeutics 2004 3 11 1485 1492 2-s2.0-9444259316 (Pubitemid 39562593)
12. Ohga T., Koike K., Ono M., Makino Y., Itagaki Y., Tanimoto M., Kuwano M., Kohno K., Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Research 1996 56 18 4224 4228 2-s2.0-0029788450 (Pubitemid 26305020)
13. Evdokimova V., Ruzanov P., Anglesio M. S., Sorokin A. V., Ovchinnikov L. P., Buckley J., Triche T. J., Sonenberg N., Sorensen P. H. B., Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Molecular and Cellular Biology 2006 26 1 277 292 2-s2.0-33645218804 10.1128/MCB.26.1.277-292. 2006
14. Sutherland B. W., Kucab J., Wu J., Lee C., Cheang M. C. U., Yorida E., Turbin D., Dedhar S., Nelson C., Pollak M., Grimes H. L., Miller K., Badve S., Huntsman D., Blake-Gilks C., Chen M., Pallen C. J., Dunn S. E., Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 2005 24 26 4281 4292 2-s2.0-20544455061 10.1038/sj.onc.1208590 (Pubitemid 40961781)
15. Bader A. G., Felts K. A., Jiang N., Chang H. W., Vogt P. K., Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway. Proceedings of the National Academy of Sciences of the United States of America 2003 100 21 12384 12389 2-s2.0-0142091357 10.1073/pnas.2135336100 (Pubitemid 37271569)
16. Chen G., Teicher B. A., Frei E. III, Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells. Anticancer Research 1996 16 6 3499 3506 2-s2.0-0030513617 (Pubitemid 127540810)
17. Zhou J., Liu M., Aneja R., Chandra R., Lage H., Joshi H. C., Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Research 2006 66 1 445 452 2-s2.0-31544463321 10.1158/0008-5472.CAN-05-1779 (Pubitemid 43166053)
18. Liu M., Li D., Aneja R., Joshi H. C., Xie S., Zhang C., Zhou J., PO2-dependent differential regulation of multidrug resistance 1 gene expression by the c-Jun NH2-terminal kinase pathway. Journal of Biological Chemistry 2007 282 24 17581 17586 2-s2.0-34547126693 10.1074/jbc.M702206200 (Pubitemid 47100273)
19. Chen G. K., Sale S., Tan T., Ermoian R. P., Sikic B. I., CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells. Molecular Pharmacology 2004 65 4 906 916 2-s2.0-1842533016 10.1124/mol.65.4.906 (Pubitemid 38420496)
20. Ogretmen B., Safa A. R., Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF- b/p65 and c-Fos transcription factors and their interaction with the CAAT region. Biochemistry 1999 38 7 2189 2199 2-s2.0-0033573850 10.1021/bi982236+ (Pubitemid 29094169)
21. Katoh S.-Y., Ueno M., Takakura N., Involvement of MDR1 function in proliferation of tumour cells. Journal of Biochemistry 2008 143 4 517 524 2-s2.0-41349093334 10.1093/jb/mvm242 (Pubitemid 351451765)
22. Yamatake Y., Shibata M., Nagai M., Pharmacological studies on root bark of mulberry tree (Morus alba L.). Japanese Journal of Pharmacology 1976 26 4 461 469 2-s2.0-0017124153
23. Nam S.-Y., Yi H.-K., Jung C. L., Jae C. K., Chang H. S., Jin W. P., Dae Y. L., Jung S. K., Pyoung H. H., Cortex Mori extract induces cancer cell apoptosis through inhibition of microtubule assembly. Archives of Pharmacal Research 2002 25 2 191 196 2-s2.0-0036547668 (Pubitemid 43057314)
24. Kikuchi T., Nihei M., Nagai H., Fukushi H., Tabata K., Suzuki T., Akihisa T., Albanol a from the root bark of Morus alba L. induces apoptotic cell death in HL60 human leukemia cell line. Chemical and Pharmaceutical Bulletin 2010 58 4 568 571 2-s2.0-77950856319 10.1248/cpb.58.568
25. Park S., Kim J., Kim Y., Mulberry leaf extract inhibits cancer cell stemness in neuroblastoma. Nutrition and Cancer 2012 64 889 898 10.1080/01635581.2012.707280
26. Yang Y., Gong T., Liu C., Chen R.-Y., Four new 2-arylbenzofuran derivatives from leaves of Morus alba L. Chemical and Pharmaceutical Bulletin 2010 58 2 257 260 2-s2.0-76149111962 10.1248/cpb.58.257
27. Yang Y., Zhang T., Xiao L., Yang L., Chen R., Two new chalcones from leaves of Morus alba L. Fitoterapia 2010 81 6 614 616 2-s2.0-77955709591 10.1016/j.fitote.2010.03.005
28. Deepa M., Priya S., Purification and characterization of a novel anti-proliferative lectin from Morus alba L. leaves. Protein & Peptide Letters 2012 19 839 845 10.2174/092986612801619516
29. Deepa M., Sureshkumar T., Satheeshkumar P. K., Priya S., Purified mulberry leaf lectin (MLL) induces apoptosis and cell cycle arrest in human breast cancer and colon cancer cells. Chemico-Biological Interactions 2012 200 38 44 10.1016/j.cbi.2012.08.025
30. Hu Z., Jin S., Scotto K. W., Transcriptional activation of the MDR1 gene by UV irradiation: role of NF-Y and Sp1. Journal of Biological Chemistry 2000 275 4 2979 2985 2-s2.0-0034723353 10.1074/jbc.275.4.2979 (Pubitemid 30082076)
31. Nooter K., Westerman A. M., Flens M. J., Zaman G. J. R., Scheper R. J., Van Wingerden K. E., Burger H., Oostrum R., Boersma T., Sonneveld P., Gratama J. W., Kok T., Eggermont A. M. M., Bosman F. T., Stoter G., Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clinical Cancer Research 1995 1 11 1301 1310 2-s2.0-0028855891
32. Oue T., Yoneda A., Uehara S., Yamanaka H., Fukuzawa M., Increased expression of multidrug resistance-associated genes after chemotherapy in pediatric solid malignancies. Journal of Pediatric Surgery 2009 44 2 377 380 2-s2.0-60149102466 10.1016/j.jpedsurg.2008.10.088
33. Wattanapitayakul S. K., Chularojmontri L., Herunsalee A., Charuchongkolwongse S., Niumsakul S., Bauer J. A., Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity. Basic and Clinical Pharmacology and Toxicology 2005 96 1 80 87 2-s2.0-13844318812 10.1111/j.1742-7843.2005.pto960112.x (Pubitemid 40260851)
34. Yan F., Wang X.-M., Liu Z.-C., Pan C., Yuan S.-B., Ma Q.-M., JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrugresistance of hepatocellular carcinoma cells. Hepatobiliary and Pancreatic Diseases International 2010 9 3 287 295 2-s2.0-77953830891
35. Tang P. M.-K., Zhang D.-M., Xuan B. N.-H., Tsui S. K.-W., Waye M. M.-Y., Kong S.-K., Fong W.-P., Fung K.-P., Photodynamic therapy inhibits p-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a. Molecular Cancer 2009 8, article 56 2-s2.0-69549126244 10.1186/1476-4598-8-56
36. Bark H., Choi C.-H., Psc833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF- B. Cancer Chemotherapy and Pharmacology 2010 65 6 1131 1136 2-s2.0-77951890193 10.1007/s00280-009-1121-7
37. Kawasaki K., Watanabe M., Sakaguchi M., Ogasawara Y., Ochiai K., Nasu Y., Doihara H., Kashiwakura Y., Huh N.-H., Kumon H., Date H., REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Therapy 2009 16 1 65 72 2-s2.0-57649122080 10.1038/cgt.2008.58
38. Miao Z.-H., Ding J., Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Research 2003 63 15 4527 4532 2-s2.0-0042591363 (Pubitemid 36951025)
39. Comerford K. M., Cummins E. P., Taylor C. T., c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1 α -dependent P-glycoprotein expression in hypoxia. Cancer Research 2004 64 24 9057 9061 2-s2.0-10844278331 10.1158/0008-5472.CAN-04-1919 (Pubitemid 39665517)
40. Sui H., Zhou S., Wang Y., Liu X., Zhou L., Yin P., Fan Z., Li Q., COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Carcinogenesis 2011 32 5 667 675 2-s2.0-79955775908 10.1093/carcin/bgr016